By Stewart Eisenhart, Emergo Group
Indian regulators have recently announced several updates regarding their medical device and IVD oversight programs.
Get the full story here at the Emergo Group’s blog.
The opinions expressed in this blog post are the author’s only and do not necessarily reflect those of DrugDeliveryBusiness.com or its employees.